Michael R Hayden's Net Worth

$2.08 Million

Estimate Recalculated Nov 3, 2024 09:39PM EST

Who is Michael R Hayden?

Michael R Hayden has an estimated net worth of $2.08 Million. This is based on reported shares across multiple companies, which include Aurinia Pharmaceuticals Inc., Xenon Pharmaceuticals Inc., AbCellera Biologics Inc., IONIS PHARMACEUTICALS INC, and 89bio, Inc..

SEC CIK

Michael R Hayden's CIK is 0001352908

Past Insider Trading and Trends

2021 was Michael R Hayden's most active year for acquiring shares with 14 total transactions. Michael R Hayden's most active month to acquire stocks was the month of June. 2021 was Michael R Hayden's most active year for disposing of shares, totalling 9 transactions. Michael R Hayden's most active month to dispose stocks was the month of June. 2021 saw Michael R Hayden paying a total of $722,336.38 for 294,439 shares, this is the most they've acquired in one year. In 2021 Michael R Hayden cashed out on 184,792 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Aurinia Pharmaceuticals Inc. (AUPH) Snapshot price: $7.4

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
95K
$5.79
$550,100.00
95K
Jan 29
Form 3
—
0
—
—
0
No matching records found

Xenon Pharmaceuticals Inc. (XENE) Snapshot price: $38.47

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

AbCellera Biologics Inc. (ABCL) Snapshot price: $2.42

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
+1.53%
20K
$4.91
$98,200.00
1.32M
Sep 22
Form 4
+2.36%
30K
$5.90
$177,000.00
1.3M
Aug 8
Form 4
—
0
—
—
0
Dec 1
Form 4
—
0
—
—
0
Aug 27 - Dec 7
Form 4
+26.91%
270K
$17.73
$4,787,100.00
1.27M
Sep 13
Form 4
-9.06%
-100.00K
$25.50
-$2,550,000.00
1M
Jun 22
Form 4
+60.67%
461.31K
$10.16
$1,473,300.00
1.22M
Nov 6 - Dec 15
Form 3
—
0
—
—
0
No matching records found

IONIS PHARMACEUTICALS INC (IONS) Snapshot price: $46.89

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 1
Form 4
+30.77%
7.11K
—
—
30.22K
Jul 17
Form 4
—
0
—
—
0
Jul 3
Form 4
+8.33%
1.78K
—
—
23.11K
Oct 17
Form 4
+49.99%
7.11K
—
—
21.33K
Jul 15
Form 4
—
0
—
—
0
Jul 1
Form 4
+14.28%
1.78K
—
—
14.22K
Oct 15
Form 4
+133.31%
7.11K
—
—
12.45K
Jul 15
Form 4
—
0
—
—
0
Jul 1
Form 4
+50.00%
1.78K
—
—
5.33K
Oct 15
Form 4
+100.00%
1.78K
—
—
3.56K
Jul 1
Form 4
∞
1.78K
—
—
1.78K
Oct 15
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Oct 15
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Sep 20
No matching records found

89bio, Inc. (ETNB) Snapshot price: $8.47

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 1
Form 4
+112.94%
87.79K
$9.67
$1,077,913.70
165.52K
Mar 30 - Mar 28
Form 4
—
0
—
—
0
Feb 9
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
Apr 15
Form 4
∞
80.9K
$2.13
$172,236.38
80.9K
Feb 23
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Apr 5
Form 4
∞
77.73K
$16.00
—
77.73K
Nov 11 - Nov 13
Form 3
—
0
—
—
0
No matching records found